Expression and prognostic value of the standard CD44 protein in pulmonary adenocarcinoma.

  • Authors:
    • I Takanami
    • K Takeuchi
    • M Naruke
  • View Affiliations

  • Published online on: September 1, 2000     https://doi.org/10.3892/or.7.5.1065
  • Pages: 1065-1072
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We examined immunohistochemically the expression of the standard form of CD44 (CD44S) tissue specimens from 164 patients with pulmonary adenocarcinoma. Of the 164 specimens, 79 (48%) expressed CD44S and the incidence of expression correlated with the tumor size. The prognosis for CD44S positive patients was poorer than that of CD44S negative patients. Our findings suggest that CD44S plays an important role in tumor progression and that CD44S expression is a useful prognostic marker for pulmonary adenocarcinomas.

Related Articles

Journal Cover

Sep-Oct 2000
Volume 7 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Takanami I, Takeuchi K and Naruke M: Expression and prognostic value of the standard CD44 protein in pulmonary adenocarcinoma.. Oncol Rep 7: 1065-1072, 2000
APA
Takanami, I., Takeuchi, K., & Naruke, M. (2000). Expression and prognostic value of the standard CD44 protein in pulmonary adenocarcinoma.. Oncology Reports, 7, 1065-1072. https://doi.org/10.3892/or.7.5.1065
MLA
Takanami, I., Takeuchi, K., Naruke, M."Expression and prognostic value of the standard CD44 protein in pulmonary adenocarcinoma.". Oncology Reports 7.5 (2000): 1065-1072.
Chicago
Takanami, I., Takeuchi, K., Naruke, M."Expression and prognostic value of the standard CD44 protein in pulmonary adenocarcinoma.". Oncology Reports 7, no. 5 (2000): 1065-1072. https://doi.org/10.3892/or.7.5.1065